CRON — what changed in the latest 10-Q

Text added vs the prior filing · source: 10-Q · 2026-11-05

• •expectations related to our acquisition of CanAdelaar B.V. (“CanAdelaar”), including the anticipated costs, benefits and integration matters associated therewith and the performance of the business from and following closing, the outcome of regulatory and judicial proceedings involving CanAdelaar, …

• On October 15, 2026, the Company and its wholly owned subsidiary, CGM B.V. (“CGM”), completed the acquisition of all of the issued and outstanding shares of CanAdelaar, one of ten licensed cannabis growers in the Dutch Controlled Cannabis Supply Chain Experiment. At closing, CGM waived all of its co…

• Three months ended September 30,Nine months ended September 30,

• Net income attributable to non-controlling interest4,0222,3639,5595,193

• Three months ended September 30,ChangeNine months ended September 30,Change

Text removed vs the prior filing · source: 10-Q · 2026-08-06

• •expectations related to our agreement to acquire CanAdelaar B.V. (“CanAdelaar”), including the timing and completion of the transaction, and the anticipated costs, benefits and integration matters associated therewith and the performance of the business from and following closing;

• On December 9, 2025, the Company entered into a definitive share sale and purchase agreement (the “SPA”) to acquire all of the issued and outstanding shares of CanAdelaar, one of ten licensed cannabis producers participating in the Dutch Controlled Cannabis Supply Chain Experiment.

• On May 8, 2026, the Company entered into an amendment to the SPA pursuant to which the parties agreed to extend the Long Stop Date (as defined in the SPA) for closing of the acquisition from June 9, 2026 to September 9, 2026. The extension provides additional time to satisfy certain closing conditio…

• The Company expects the acquisition to close in the second half of 2026.

• The Middle East Conflict, including the recent escalation involving the United States, Israel and Iran, has contributed to increased energy and shipping costs. The impact of these cost increases on the Company’s results for the three and six months ended June 30, 2026 was not material. The Company i…

Text added vs the prior filing · source: 10-Q · 2026-11-05

• Our acquisition of CanAdelaar exposes us to integration challenges and unresolved regulatory and environmental matters that could adversely affect its operations and the anticipated benefits of the acquisition.

• On October 15, 2026, we completed the acquisition of CanAdelaar, a licensed cannabis producer participating in the Dutch Controlled Cannabis Supply Chain Experiment (the “Wietexperiment”). The integration of CanAdelaar’s operations, personnel, technology and compliance systems may require greater re…

• At closing, we waived the condition relating to the final, non-appealable decision from the Minister of Health, Welfare, and Sport concerning the Bibob review, a background check conducted by Dutch authorities, and related advice of the National Bibob Office, which remained outstanding. An adverse o…

• CanAdelaar is also subject to a proposed penalty notice issued by DCMR Environmental Service Rijnmond relating to alleged odor nuisance, the amount of which was deducted from the estimated initial purchase price payable at closing, subject to adjustment based on any final penalty imposed. The final …

• CanAdelaar operates under a newly established, experimental and highly regulated framework. Changes to applicable requirements, changes to consumer preferences or behavior in the market, difficulties maintaining compliance or modification, suspension or